Cell transplantation for heart disease: The clinical perspective

Evidence-based Cardiovascular Medicine

Volumn 9, Issue 1, 2005, Pages 2-7

  Yang, Simon ^a   Fazel, Shafie ^a   Angoulvant, Denis ^a   Weisel, Richard D ^a   Li, Ren Ke ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; VASCULOTROPIN;

ACUTE HEART INFARCTION; ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; BONE MARROW TRANSPLANTATION; CARDIAC GRAFT REJECTION; CELL TRANSPLANTATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; EDITORIAL; HEART CELL CULTURE; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

ANIMALS; CELL TRANSPLANTATION; CLINICAL TRIALS; HEART DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MYOBLASTS; MYOBLASTS, CARDIAC; MYOBLASTS, SKELETAL;

EID: 15544368933     PISSN: 13612611     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ebcm.2005.01.045     Document Type: Editorial

References (32)

1. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76.
2. Allen RE, Rankin LL. Regulation of satellite cells during skeletal muscle growth and development. Proc Soc Exp Biol Med 1990;194:81-6.
3. Leor J, Prentice H, Sartorelli V, et al. Gene transfer and cell transplant: An experimental approach to repair a 'broken heart'. Cardiovasc Res 1997;35:431-41.
4. Haider HK, Tan AC, Aziz S, et al. Myoblast transplantation for cardiac repair: A clinical perspective. Mol Ther 2004;9:14-23.
5. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-83.
6. Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003;24:2012-20.
7. Dib N, McCarthy P, Campbell A, et al. Two-year follow-up of the safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Results from the United States experience. Circulation 2003;108(IV):623.
8. Smits PC, van Geuns RJ, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with six-month follow-up. J Am Coll Cardiol 2003;42:2063-9.
9. Thompson CA, Nasseri BA, Makower J, et al. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 2003;41:1964-71.
10. Siminiak T, Fiszer D, Jerzykowska O, et al. Percutaneous autologous myoblast transplantation in the treatment of post-infarction myocardial contractility impairment - report on two cases. Kardiol Pol 2003;59:492-501.
11. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-88.
12. Leobon B, Garcin I, Menasche P, et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003;100:7808-11.
13. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
14. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8.
15. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-8.
16. Assmus B, Schachinger V, Britten M, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): Migratory capacity of transplanted progenitor cells predicts functional improvement and infarct size reduction. Circulation 2003;108 (IV):311.
17. Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776-9.
18. Iwaguro H, Yamaguchi J, Kalka C, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732-8.
19. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 2004;363:751-6.
20. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004;364:141-8.
21. Tse HF, Kwong YL, Chan JK, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361:47-9.
22. Fuchs S, Satler LF, Kornowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: A feasibility study. J Am Coll Cardiol 2003;41:1721-4.
23. Perin EC, Dohmann HF, Borojevic R, et al. Improvement in exercise capacity and ischemia at six months following transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2003;108 (IV):618.
24. Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6.
25. Galinanes M, Loubani M, Davies J, et al. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant 2004;13:7-13.
26. Koh GY, Soonpaa MH, Klug MG, et al. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest 1995;96:2034-42.
27. Angoulvant D, Fazel S, and Li RK. Neovascularization derived from cell transplantation in ischemic myocardium. Mol Cell Biochem 2004. [In press]
28. Kim HE, Dalal SS, Young E, et al. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J Clin Invest 2000;106:857-66.
29. American Heart Association. Heart Disease and Stroke Statistics - 2004 Update. 2004.
30. Heeschen C, Lehmann R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109:1615-22.
31. Aviles FF, San Roman JA, Garcia FJ, et al. Intracoronary stem cell transplantation in acute myocardial infarction. Rev Esp Cardiol 2004;57:201-8.
32. Engelmann MG, Theiss H, Wintersperger B, et al. Placebo-controlled, randomized, double-blind study on the efficacy of bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor (G-CSF) on improvement of ischemic heart failure undergoing delayed revascularization for ST segment elevation myocardial infarction (STEMI). Circulation 2003;108(IV):618.